China Bicalutamide Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Bicalutamide industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • ANI Pharmaceuticals

    • Actavis Pharma

    • Zhejiang Haizheng Pharmaceutical

    • Accel Pharma

    • Sivem Pharmaceuticals

    • Apotex Corporation

    • CORDEN PHARMA GMBH

    • Shanghai Fudan Fuhua Pharmaceutical

    • Shanxi Zhendong Pharmaceutical

    • AstraZeneca

    • Zeneca GmbH

    • Shanghai Zhaohui Pharmaceutical

    By Type:

    • Tablets

    • Capsule

    By Application:

    • Single Drug For Prostate Cancer

    • Combined Chemotherapy For Prostate Cancer

    • Combined Radiation Therapy Or Castration For Prostate Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Bicalutamide Market Overview 2018-2029

    • 1.1 China Bicalutamide Industry Development Overview

    • 1.2 China Bicalutamide Industry Development History

    • 1.3 China Bicalutamide Industry Market Size (2018-2029)

    • 1.4 China Bicalutamide Market Analysis by Type from Production Side

      • 1.4.1 China Bicalutamide Production Volume, Production Value and Growth Rate of Tablets (2018-2029)

      • 1.4.2 China Bicalutamide Production Volume, Production Value and Growth Rate of Capsule (2018-2029)

    • 1.5 China Bicalutamide Market Analysis by Application from Consumption End

      • 1.5.1 China Bicalutamide Sales Volume, Sales Value and Growth Rate of Single Drug For Prostate Cancer (2018-2029)

      • 1.5.2 China Bicalutamide Sales Volume, Sales Value and Growth Rate of Combined Chemotherapy For Prostate Cancer (2018-2029)

      • 1.5.3 China Bicalutamide Sales Volume, Sales Value and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer (2018-2029)

    • 1.6 China Bicalutamide Market Analysis by Region

      • 1.6.1 North China Bicalutamide Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Bicalutamide Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Bicalutamide Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Bicalutamide Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Bicalutamide Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Bicalutamide Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Bicalutamide Market Size and Growth Rate from 2018-2029

    Chapter 2 China Bicalutamide Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Bicalutamide Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Bicalutamide Market Status and Competition Analysis in 2023

      • 2.2.3 China Bicalutamide Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Bicalutamide Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Bicalutamide Industry Development

    Chapter 3 BicalutamideIndustry Chain Analysis

    • 3.1 Bicalutamide Industry Chain

    • 3.2 Bicalutamide Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Bicalutamide Market

    • 3.3 Bicalutamide Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Bicalutamide Market

    Chapter 4 China Bicalutamide Market, by Type

    • 4.1 China Bicalutamide Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Bicalutamide Total Production Volume and Growth Rate from Production Side

    • 4.5 China Bicalutamide Production Volume and Growth Rate, by Type

      • 4.5.1 China Bicalutamide Production Volume and Growth Rate of Tablets

      • 4.5.2 China Bicalutamide Production Volume and Growth Rate of Capsule

    Chapter 5 China Bicalutamide Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Bicalutamide Total Market Size and Growth Rate from Consumption End

    • 5.5 China Bicalutamide Market Size and Growth Rate, by Application

      • 5.5.1 China Bicalutamide Market Size and Growth Rate of Single Drug For Prostate Cancer

      • 5.5.2 China Bicalutamide Market Size and Growth Rate of Combined Chemotherapy For Prostate Cancer

      • 5.5.3 China Bicalutamide Market Size and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer

    Chapter 6 China Bicalutamide Market, by Region

    • 6.1 China Bicalutamide Production Volume and Production Value, by Region

    • 6.2 China Bicalutamide Sales Volume and Sales Value, by Region

    Chapter 7 North China Bicalutamide Market Analysis

    • 7.1 North China Bicalutamide Market, by Type

    • 7.2 North China Bicalutamide Market, by Application

    Chapter 8 Central China Bicalutamide Market Analysis

    • 8.1 Central China Bicalutamide Market, by Type

    • 8.2 Central China Bicalutamide Market, by Application

    Chapter 9 South China Bicalutamide Market Analysis

    • 9.1 South China Bicalutamide Market, by Type

    • 9.2 South China Bicalutamide Market, by Application

    Chapter 10 East China Bicalutamide Market Analysis

    • 10.1 East China Bicalutamide Market, by Type

    • 10.2 East China Bicalutamide Market, by Application

    Chapter 11 Northeast China Bicalutamide Market Analysis

    • 11.1 Northeast China Bicalutamide Market, by Type

    • 11.2 Northeast China Bicalutamide Market, by Application

    Chapter 12 Southwest China Bicalutamide Market Analysis

    • 12.1 Southwest China Bicalutamide Market, by Type

    • 12.2 Southwest China Bicalutamide Market, by Application

    Chapter 13 Northwest China Bicalutamide Market Analysis

    • 13.1 Northwest China Bicalutamide Market, by Type

    • 13.2 Northwest China Bicalutamide Market, by Application

    Chapter 14 Company Profiles

      • 14.1 ANI Pharmaceuticals

        • 14.1.1 ANI Pharmaceuticals Company Profile

        • 14.1.2 ANI Pharmaceuticals Bicalutamide Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Actavis Pharma

        • 14.2.1 Actavis Pharma Company Profile

        • 14.2.2 Actavis Pharma Bicalutamide Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Zhejiang Haizheng Pharmaceutical

        • 14.3.1 Zhejiang Haizheng Pharmaceutical Company Profile

        • 14.3.2 Zhejiang Haizheng Pharmaceutical Bicalutamide Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Accel Pharma

        • 14.4.1 Accel Pharma Company Profile

        • 14.4.2 Accel Pharma Bicalutamide Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sivem Pharmaceuticals

        • 14.5.1 Sivem Pharmaceuticals Company Profile

        • 14.5.2 Sivem Pharmaceuticals Bicalutamide Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Apotex Corporation

        • 14.6.1 Apotex Corporation Company Profile

        • 14.6.2 Apotex Corporation Bicalutamide Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 CORDEN PHARMA GMBH

        • 14.7.1 CORDEN PHARMA GMBH Company Profile

        • 14.7.2 CORDEN PHARMA GMBH Bicalutamide Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Shanghai Fudan Fuhua Pharmaceutical

        • 14.8.1 Shanghai Fudan Fuhua Pharmaceutical Company Profile

        • 14.8.2 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Shanxi Zhendong Pharmaceutical

        • 14.9.1 Shanxi Zhendong Pharmaceutical Company Profile

        • 14.9.2 Shanxi Zhendong Pharmaceutical Bicalutamide Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 AstraZeneca

        • 14.10.1 AstraZeneca Company Profile

        • 14.10.2 AstraZeneca Bicalutamide Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Zeneca GmbH

        • 14.11.1 Zeneca GmbH Company Profile

        • 14.11.2 Zeneca GmbH Bicalutamide Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Shanghai Zhaohui Pharmaceutical

        • 14.12.1 Shanghai Zhaohui Pharmaceutical Company Profile

        • 14.12.2 Shanghai Zhaohui Pharmaceutical Bicalutamide Market Performance

        • 14.12.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Bicalutamide Industry Research Conclusions

    • 15.2 Bicalutamide Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Bicalutamide Industry Market Size (2018-2029)

    • Figure China Bicalutamide Production Volume, Production Value and Growth Rate of Tablets (2018-2029)

    • Figure China Bicalutamide Production Volume, Production Value and Growth Rate of Capsule (2018-2029)

    • Figure China Bicalutamide Sales Volume, Sales Value and Growth Rate of Single Drug For Prostate Cancer (2018-2029)

    • Figure China Bicalutamide Sales Volume, Sales Value and Growth Rate of Combined Chemotherapy For Prostate Cancer (2018-2029)

    • Figure China Bicalutamide Sales Volume, Sales Value and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer (2018-2029)

    • Figure North China Bicalutamide Market Size and Growth Rate from 2018-2029

    • Figure Central China Bicalutamide Market Size and Growth Rate from 2018-2029

    • Figure South China Bicalutamide Market Size and Growth Rate from 2018-2029

    • Figure East China Bicalutamide Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Bicalutamide Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Bicalutamide Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Bicalutamide Market Size and Growth Rate from 2018-2029

    • Figure Bicalutamide Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Bicalutamide Market Share by Type in 2018

    • Figure China Bicalutamide Market Share by Type in 2023

    • Figure China Bicalutamide Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Bicalutamide Production Volume and Growth Rate of Tablets (2018-2023)

    • Figure China Bicalutamide Production Volume and Growth Rate of Capsule (2018-2023)

    • Figure China Bicalutamide Market Share by Application in 2018

    • Figure China Bicalutamide Market Share by Application in 2023

    • Figure China Bicalutamide Total Market Size and Growth Rate from Consumption End

    • Figure China Bicalutamide Market Size and Growth Rate of Single Drug For Prostate Cancer (2018-2023)

    • Figure China Bicalutamide Market Size and Growth Rate of Combined Chemotherapy For Prostate Cancer (2018-2023)

    • Figure China Bicalutamide Market Size and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer (2018-2023)

    • Table China Bicalutamide Production Volume by Region (2018-2023)

    • Table China Bicalutamide Production Volume Share by Region (2018-2023)

    • Figure China Bicalutamide Production Volume Share by Region (2018-2023)

    • Table China Bicalutamide Production Value by Region (2018-2023)

    • Table China Bicalutamide Production Value Share by Region (2018-2023)

    • Figure China Bicalutamide Production Value Share by Region (2018-2023)

    • Table China Bicalutamide Sales Volume by Region (2018-2023)

    • Table China Bicalutamide Sales Volume Share by Region (2018-2023)

    • Figure China Bicalutamide Sales Volume Share by Region (2018-2023)

    • Table China Bicalutamide Sales Value by Region (2018-2023)

    • Table China Bicalutamide Sales Value Share by Region (2018-2023)

    • Figure China Bicalutamide Sales Value Share by Region (2018-2023)

    • Table North China Bicalutamide Production Volume by Type (2018-2023)

    • Table North China Bicalutamide Production Volume Share by Type (2018-2023)

    • Figure North China Bicalutamide Production Volume Share by Type (2018-2023)

    • Table North China Bicalutamide Sales Volume by Application (2018-2023)

    • Table North China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Figure North China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Table Central China Bicalutamide Production Volume by Type (2018-2023)

    • Table Central China Bicalutamide Production Volume Share by Type (2018-2023)

    • Figure Central China Bicalutamide Production Volume Share by Type (2018-2023)

    • Table Central China Bicalutamide Sales Volume by Application (2018-2023)

    • Table Central China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Figure Central China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Table South China Bicalutamide Production Volume by Type (2018-2023)

    • Table South China Bicalutamide Production Volume Share by Type (2018-2023)

    • Figure South China Bicalutamide Production Volume Share by Type (2018-2023)

    • Table South China Bicalutamide Sales Volume by Application (2018-2023)

    • Table South China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Figure South China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Table East China Bicalutamide Production Volume by Type (2018-2023)

    • Table East China Bicalutamide Production Volume Share by Type (2018-2023)

    • Figure East China Bicalutamide Production Volume Share by Type (2018-2023)

    • Table East China Bicalutamide Sales Volume by Application (2018-2023)

    • Table East China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Figure East China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Table Northeast China Bicalutamide Production Volume by Type (2018-2023)

    • Table Northeast China Bicalutamide Production Volume Share by Type (2018-2023)

    • Figure Northeast China Bicalutamide Production Volume Share by Type (2018-2023)

    • Table Northeast China Bicalutamide Sales Volume by Application (2018-2023)

    • Table Northeast China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Table Southwest China Bicalutamide Production Volume by Type (2018-2023)

    • Table Southwest China Bicalutamide Production Volume Share by Type (2018-2023)

    • Figure Southwest China Bicalutamide Production Volume Share by Type (2018-2023)

    • Table Southwest China Bicalutamide Sales Volume by Application (2018-2023)

    • Table Southwest China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Table Northwest China Bicalutamide Production Volume by Type (2018-2023)

    • Table Northwest China Bicalutamide Production Volume Share by Type (2018-2023)

    • Figure Northwest China Bicalutamide Production Volume Share by Type (2018-2023)

    • Table Northwest China Bicalutamide Sales Volume by Application (2018-2023)

    • Table Northwest China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Bicalutamide Sales Volume Share by Application (2018-2023)

    • Table ANI Pharmaceuticals Company Profile

    • Table ANI Pharmaceuticals Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Actavis Pharma Company Profile

    • Table Actavis Pharma Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Zhejiang Haizheng Pharmaceutical Company Profile

    • Table Zhejiang Haizheng Pharmaceutical Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Accel Pharma Company Profile

    • Table Accel Pharma Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Sivem Pharmaceuticals Company Profile

    • Table Sivem Pharmaceuticals Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Apotex Corporation Company Profile

    • Table Apotex Corporation Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table CORDEN PHARMA GMBH Company Profile

    • Table CORDEN PHARMA GMBH Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Shanghai Fudan Fuhua Pharmaceutical Company Profile

    • Table Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Shanxi Zhendong Pharmaceutical Company Profile

    • Table Shanxi Zhendong Pharmaceutical Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Zeneca GmbH Company Profile

    • Table Zeneca GmbH Bicalutamide Revenue, Price and Gross (2018-2023)

    • Table Shanghai Zhaohui Pharmaceutical Company Profile

    • Table Shanghai Zhaohui Pharmaceutical Bicalutamide Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.